Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yikou Sizi San is a Traditional Chinese Medicine (TCM) herbal compound used as an external hot compress treatment to promote gastrointestinal motility and recovery. It is a multi-herb formulation consisting of four primary ingredients: Fructus Evodiae (Wu Zhu Yu), Fructus Amomum tsaoko (Cao Guo), Alpiniae katsumadai (Cao Dou Kou), and Fructus Alpiniae oxyphyllae (Yi Zhi Ren). The therapy is typically applied topically to the Shenque acupuncture point (navel area) in patients suffering from postoperative gastrointestinal dysfunction (PGD), particularly following abdominal surgeries such as laparoscopic colorectal cancer surgery or laparoscopic total hysterectomy. The proposed biological mechanism under investigation involves the modulation of ghrelin signaling to enhance gastrointestinal transit. The therapy is associated with the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, where it has been evaluated in randomized controlled clinical trials.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yikou Sizi San.